ARTICLE | Clinical News

BD Max Cdiff Assay regulatory update

April 9, 2012 7:00 AM UTC

Becton Dickinson's BD Diagnostics segment received CE Mark approval for its BD Max Cdiff Assay for use on the company's BD MAX system to detect Clostridium difficile infection. BD Diagnostics said the assay detects the toxin B gene, which is present in toxigenic C. difficile and is essential for disease. The assay is currently available. ...